The European Medicines Agency will review drugs similar to Vioxx after Merck withdrew it due to increased stroke and heart attack risks.
Despite previous reviews, Vioxx was pulled globally, prompting lawsuits and financial losses for Merck.
The FDA is also investigating related drugs like Bextra.
Celebrex, another drug in the same class, is under scrutiny for its safety.
Vioxx's withdrawal has sparked concerns about cardiovascular risks associated with similar medications.
Legal actions against Merck are mounting, with potential implications for future drug recalls and patient safety.
